NextCure, Inc.
- NXTC
- NASDAQ
- Biotechnology
- Immuno-Oncology
- Clinical-Stage Biopharma
$6.24
Today −9.30%Quote Oct 16, 2026, 08:00 PM UTC
+10.05%over the last month
Max drawdown −21.2%From 1-month high −13.1%3 months +15.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$28.6M
Quote Oct 16
Next earnings
Nov 4
Expected, not confirmed
Analyst target
$20.00
+220.5% from here
Floor
$5.80
7.0% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about NXTCPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
40